Vaccine contents


PUBLISHED: 2017 CATEGORY: Health care providers, Parents, Adults TYPE: PDFImmunization: Get the Facts

Immunization: Get the Facts

This pamphlet answers common misconceptions and questions about vaccines. Revised and updated in 2017.

Corporate Authors: Immunize Canada
Publisher: Immunize Canada

PUBLISHED: 2017 CATEGORY: Les fournisseurs de soins, Parents, Adultes TYPE: PDFLa vaccination : informez-vous

La vaccination : informez-vous

Ce dépliant répond aux questions courantes et aux idées fausses au sujet de la vaccination. Revisé et mis à jour en 2017.

Corporate Authors: Immunisation Canada
Publisher: Immunisation Canada

PUBLISHED: 2017 CATEGORY: Health care providers, Parents TYPE: External Link Talking about Vaccines: Thimerosal

Talking about Vaccines: Thimerosal

Thimerosal (ethyl mercury) is a widely used preservative in biologic and medical products. Since 2001, all vaccines routinely recommended for children 6 years of age and younger are thimerosal-free, with the exception of some formulations of inactivated influenza vaccine. Numerous studies have since shown that there is no relationship between vaccines, either with or without thimerosal, and the development of autism or other neurologic problems in children.

Corporate Authors: Immunization Action Coalition
Publisher: Immunization Action Coalition

PUBLISHED: 2016 CATEGORY: Parents, Health care providers, Adults TYPE: External Link 'Nosodes' are no substitute for vaccines (CPS Position Statement)

'Nosodes' are no substitute for vaccines (CPS Position Statement)

A growing antivaccine movement in Canada and elsewhere is hearing more about an unproven homeopathic therapy, ‘nosodes’, as an alternative to routine vaccines. The present statement defines nosodes and describes limitations for their use in children. There is scant evidence in the medical literature for either the efficacy or safety of nosodes, which have not been well studied for the prevention of any infectious disease in humans. Recommendations to change the labelling on these products to reflect such limitations are made.

Authors: Rieder M, Robinson J
Corporate Authors: Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee, Infectious Diseases and Immunization Committee
Publisher: Canadian Paediatric Society

PUBLISHED: 2016 CATEGORY: Health care providers TYPE: External Link Canadian Immunization Guide: Evergreen Edition

Canadian Immunization Guide: Evergreen Edition

Evergreen edition presents information on the immunizing agents available in Canada and their use in the prevention of communicable diseases.

Corporate Authors: National Advisory Committee on Immunization
Publisher: Public Health Agency of Canada

PUBLISHED: 2016 CATEGORY: Les fournisseurs de soins TYPE: External Link Guide canadien d'immunisation : Edition évolutive

Guide canadien d'immunisation : Edition évolutive

Le présent Guide (édition évolutive) contient des renseignements sur les agents immunisants disponibles au Canada et sur leur utilisation en vue de prévenir les maladies transmissibles.

Corporate Authors: Comité consultatif national de l'immunisation
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2016 CATEGORY: Parents, Les fournisseurs de soins, Adultes TYPE: External Link Les « nosodes » ne remplacent pas les vaccins

Les « nosodes » ne remplacent pas les vaccins

Un mouvement croissant d’opposition à la vaccination au Canada et ailleurs parle de plus en plus d’un traitement homéopathique non démontré, les « nosodes », pour remplacer les vaccins systématiques. Le présent document de principes contient la définition de ce que sont les nosodes et décrit les limites de leur utilisation chez les enfants. Les publications médicales offrent peu de données probantes sur l’efficacité ou l’innocuité des nosodes, qui n’ont pas fait l’objet d’études approfondies sur leur capacité à prévenir les maladies infectieuses chez les humains. La Société canadienne de pédiatrie recommande donc de modifier l’étiquetage de ces produits pour en refléter les limites.

Authors: Rieder M, Robinson J
Corporate Authors: Société canadienne de pédiatrie, Comité de pharmacologie et des substances dangereuses, Comité des maladies infectieuses et d’immunisation
Publisher: Société canadienne de pédiarie

PUBLISHED: 2015 CATEGORY: Health care providers, Adults TYPE: External Link Thimerosal (US CDC)

Thimerosal (US CDC)

Provides links to information about thimerosal.

Corporate Authors: Centers for Disease Control and Prevention
Publisher: Centers for Disease Control and Prevention

PUBLISHED: 2010 CATEGORY: Health care providers TYPE: External Link Prenatal and infant exposure to thimerosal from vaccines and immunoglobins and risk of autism

Prenatal and infant exposure to thimerosal from vaccines and immunoglobins and risk of autism

This study was designed to examine relationships between prenatal and infant ethylmercury exposure from thimerosal-containing vaccines and/or immunoglobin preparations and Autism spectrum disorder. There were no findings of increased risk.

Authors: Price CS et al.
Journal Issue: 4
Journal Title: Pediatrics
Journal Volume: 126
Publisher: American Academy of Pediatrics

PUBLISHED: 2007 CATEGORY: Health care providers TYPE: External Link Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.

Explores whether early exposure to thimerosal, a mercury-containing preservative used in vaccines and immune globulin preparations, is associated with neuropsychological deficits in children.

Authors: Thompson W et al.
Journal Issue: 13
Journal Title: New England Journal of Medicine
Journal Volume: 357
Publisher: Massachusetts Medical Society
Pubmed: 17898097